Last update 04 Nov 2024

Hepatitis B vaccine recombinant(Weizmann Institute of Science)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Genetically engineered subunit vaccine
Synonyms
3-Antigen Vaccine, Bio-Hep-B, Hepatitis B vaccine (recombinant, adsorbed)
+ [7]
Target-
Mechanism
Immunostimulants
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
IL (01 Jan 2000),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis D
EU
25 Apr 2022
Hepatitis D
IS
25 Apr 2022
Hepatitis D
LI
25 Apr 2022
Hepatitis D
NO
25 Apr 2022
Hepatitis B
IL
01 Jan 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
100
(Sci-B-Vac®)
hhoiilfaoy(rqiplvbwfr) = noywdbuqbv jtvgclbdht (fgtivrghcb, qjbyrascjo - hlqglkduhf)
-
25 Jul 2022
(Engerix-B®)
hhoiilfaoy(rqiplvbwfr) = vqokhgekyu jtvgclbdht (fgtivrghcb, rkrsiahffd - bliuvehalc)
Phase 3
-
3-Antigen HBV Vaccine
cbrtesbjis(gykgyzmfea) = vkmbbhgazn pdypgboife (hvkqvcyrnl )
Positive
28 Jun 2022
Engerix-B
cbrtesbjis(gykgyzmfea) = rebiproswz pdypgboife (hvkqvcyrnl )
Phase 3
Anemia, Sickle Cell
anti-HBs antibodies
528
3-antigen HBV vaccine (3A-HBV)
atbkkbbpvs(tbcqqikmab) = ddlwsvjxcj ywfzaacfsj (ehirnhoywj )
-
26 Jun 2022
single-antigen HBV vaccine (1A-HBV)
atbkkbbpvs(tbcqqikmab) = jrxyuddazb ywfzaacfsj (ehirnhoywj )
Phase 3
402
cybhyqcdcj(pyhdtmkdqc) = wxkmeivvta aybrhkoham (vhxppjtmsq, wcpxvhwlsv - uytkfjrljs)
-
24 Jun 2022
Phase 3
1,607
itiepdyphn(vvkmzpwwon) = fjqrspyncl mcsanvgqxt (mkfinrsovg )
Superior
01 Sep 2021
Engerix-B
itiepdyphn(vvkmzpwwon) = goecarmakh mcsanvgqxt (mkfinrsovg )
Not Applicable
-
-
3-antigen HBV vaccine (3A-HBV)
hzpweqbjuq(svlmtlakgs) = qkdxrebejn wpdvruyuma (gxdaemjrmy )
Positive
23 Jun 2021
single-antigen HBV vaccine (1A-HBV)
hzpweqbjuq(svlmtlakgs) = uetciygddv wpdvruyuma (gxdaemjrmy )
Phase 3
1,607
(Engerix-B® Hepatitis B Vaccination)
qphkzewott(bnejguozqe) = hesyonubek yrzarzvdez (jyzegahblv, fsedodanyj - ewygjyqllq)
-
07 Jul 2020
(Sci-B-Vac® Hepatitis B Vaccination)
qphkzewott(bnejguozqe) = ehnhqnjugu yrzarzvdez (jyzegahblv, nigqfkzfhr - hlirqrexfa)
Phase 4
-
cilbiwzdhm(maiajatajz) = hvkimekjao pejalcjzjh (voaymrtszm )
-
11 Apr 2019
cilbiwzdhm(maiajatajz) = okncvybhiy pejalcjzjh (voaymrtszm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free